Biomanufacturing Solutions GE Healthcare Life Sciences offers a range of bioprocess and biomanufacturing solutions to increase capabilities for cell and protein investigation, drug discovery, and large-scale manufacturing of biopharmaceuticals. This presents a sales opportunity for companies looking to enhance their biomanufacturing processes.

Gene Therapy Advancements With tools and technologies for cell & gene therapy, GE Healthcare Life Sciences enables researchers and pharmaceutical companies to bring new therapies into clinical use. This segment presents a sales opportunity for companies involved in gene therapy research and production.

Partnerships and Acquisitions Recent partnerships and acquisitions by GE Healthcare Life Sciences, such as the collaboration with RevoluGen Ltd. for genomic tools and the acquisition of Monica Healthcare for fetal monitor technology, showcase a commitment to innovation. This signifies potential partnerships or sales opportunities for companies with complementary technologies or products.

Single-Use Biomanufacturing Platforms The launch of FlexFactory single-use biomanufacturing platform-based KUBio Box by GE Healthcare Life Sciences offers a flexible and integrated environment to speed up the development of viral vector-based gene therapies. This introduces sales opportunities for companies seeking innovative single-use biomanufacturing solutions.

Next-Gen Sequencing Content Hub Through a partnership with Biocompare, GE Healthcare Life Sciences has re-launched a next-generation sequencing (NGS) content hub named Future Lab. This collaboration signifies potential sales opportunities for companies in the genomics and sequencing space looking to enhance their visibility and content offerings.